Welcome to LookChem.com Sign In|Join Free
  • or
Pyrido[3,4-g]isoquinoline is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

51521-29-0

Post Buying Request

51521-29-0 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

51521-29-0 Usage

Synthesis Reference(s)

Synthesis, p. 389, 1988 DOI: 10.1055/s-1988-27585

Check Digit Verification of cas no

The CAS Registry Mumber 51521-29-0 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 5,1,5,2 and 1 respectively; the second part has 2 digits, 2 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 51521-29:
(7*5)+(6*1)+(5*5)+(4*2)+(3*1)+(2*2)+(1*9)=90
90 % 10 = 0
So 51521-29-0 is a valid CAS Registry Number.

51521-29-0SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 15, 2017

Revision Date: Aug 15, 2017

1.Identification

1.1 GHS Product identifier

Product name pyrido[3,4-g]isoquinoline

1.2 Other means of identification

Product number -
Other names -

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:51521-29-0 SDS

51521-29-0Downstream Products

51521-29-0Relevant academic research and scientific papers

MODULATORS OF THE GLUCOCORTICOID RECEPTOR, AP-1, AND/OR NF-KB ACTIVITY AND USE THEREOF

-

Page/Page column 62, (2008/06/13)

A class of novel non-steroidal compounds are provided which are useful in treating diseases associated with modulation of the glucocorticoid receptor, AP-1, and/or NF-?B activity including obesity, diabetes, inflammatory and immune diseases, and have the structure of formula (I) its stereoisomers thereof, or a solvate thereof, or a prodrug thereof, or a pharmaceutically acceptable salt thereof, where Z is CONR1R2 or CH2NR1R2 and where at least one of X1 - X8 is N, and R, Ra, Rb, Rc and Rd are defined herein. Also provided are pharmaceutical compositions and methods of treating obesity, diabetes and inflammatory or immune associated diseases comprising said compounds.

Organic photochromic compound, a dimer of pyrido quinoline

-

, (2008/06/13)

An organic photochromic compound with improved long term preservability, thermal stability, the repetition character of the record and the like and useful as recording-memory materials or photosensitizers, comprising dimers of the compounds selected from the group consisting of pyrido[3,4-g]isoquinoline, pyrido[2,3-g]quinoline, pyrido[3,2-g]quinoline and pyrido[3,2-g]quinoline derivatives.

A Convenient Synthesis of Pyridoisoquinoline via ortho-Directed Metallation/Dimerization

Bolitt, Veronique,Mioskowski, Charles,Reddy, S. Pulla,Falck. J. R.

, p. 388 - 389 (2007/10/02)

A practical synthesis of pyridoisoquinoline was realized by a novel ortho-metallation/dimerization of N,N-diethylnicotinamide (or N,N-diethylisonicotinamide), hydriodic acid reduction of the resultant diazaanthraquinone, and catalytic dehydrogenation.

The Cyclization of N,N'-Bisisoquinoline and 3,8-Phenanthroline

Schwan, Thomas J.,Miles, Nelson J.

, p. 1351 - 1353 (2007/10/02)

The ring closure of N,N'-bis-p-xylene-α,α'-diamine dihydrochloride in fuming sulfuric acid has been investigated and the cyclization products have been identified as the linear pyridoisoquinoline as well as the previously reporte

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 51521-29-0